MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from equity
offerings, net
$78,159K
Proceeds from warrant
issuance
$11,549K
Proceeds from issuance of
shares upon exercise of...
$1,632K
Net cash provided by
financing activities
$67,362K
Effect of foreign
exchange rate changes on...
$238K
Canceled cashflow
$23,978K
Net increase
(decrease) in cash, cash...
$34,435K
Canceled cashflow
$33,165K
Cash paid for debt
extinguishment
$21,811K
Cash paid for common
stock issuance costs
-$2,167K
Noncash change in the
fair value of assets...
-$13,360K
Stock-based compensation
expense
$6,041K
Accrued liabilities
$3,975K
Loss on
extinguishment of debt
-$1,317K
Prepaid expenses and
other current assets
-$1,281K
Other expense, net
-$883K
Accounts payable
$813K
Issuance costs allocated
to pre-funded...
$706K
Depreciation and
amortization of long-term...
$443K
Noncash lease expense
$240K
Amortization of debt discount
$176K
Proceeds from sale and
maturities of securities...
$11,059K
Proceeds from sale of
other investment held...
$3,856K
Net cash used in
operating activities
-$31,935K
Net cash provided by
(used in) investing...
-$1,230K
Canceled cashflow
$29,235K
Canceled cashflow
$14,915K
Net gain (loss)
-$54,211K
Cash paid for
investments
$10,000K
Gain on other
investments
$3,794K
Unrealized foreign
exchange (gain) loss
$1,949K
Noncash change in the
fair value of digital...
$1,216K
Cash paid for digital
assets
$5,000K
Cash paid for asset
acquisition
$750K
Cash paid for
property and equipment
$395K
Back
Back
Cash Flow
source: myfinsight.com
ATAI Life Sciences N.V. (ATAI)
ATAI Life Sciences N.V. (ATAI)